Influence of Probiotics on the Development of <i>Clostridioides difficile</i> Infection in Patients Receiving Fluoroquinolones
Fluoroquinolones are associated with an increased risk of <i>Clostridioides difficile</i> infection (CDI). Probiotic supplementation has been shown to reduce the risk of antibiotic-associated diarrhea with variable effects on CDI. The objective of this study was to evaluate receipt of pr...
Main Authors: | Mary E. Sheffield, Bruce M. Jones, Blake Terrell, Jamie L. Wagner, Christopher M. Bland |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Pharmacy |
Subjects: | |
Online Access: | https://www.mdpi.com/2226-4787/9/3/141 |
Similar Items
-
Costs Associated with the Treatment of Clostridioides Difficile Infections
by: Aleksandra Sierocka, et al.
Published: (2021-07-01) -
Fecal Microbiota of Toxigenic Clostridioides difficile-Associated Diarrhea
by: Marta Hernández, et al.
Published: (2019-01-01) -
Microbiota in <i>Clostridioides difficile</i>-Associated Diarrhea: Comparison in Recurrent and Non-Recurrent Infections
by: Alessandra Gazzola, et al.
Published: (2020-09-01) -
Application of Microbiome Management in Therapy for <i>Clostridioides difficile</i> Infections: From Fecal Microbiota Transplantation to Probiotics to Microbiota-Preserving Antimicrobial Agents
by: Chun-Wei Chiu, et al.
Published: (2021-05-01) -
National Surveillance for Clostridioides difficile Infection, Sweden, 2009–2016
by: Kristina Rizzardi, et al.
Published: (2018-09-01)